CA3152734A1 — System and method of multi-drug delivery
Assigned to AbbVie Inc · Expires 2021-03-04 · 5y expired
What this patent protects
A multi-drug delivery system includes a first capsule including a first capsule body that includes a first interior, and a first tablet and a second tablet within the first interior. The first tablet includes a first drug, and the second tablet includes at least a second drug dif…
USPTO Abstract
A multi-drug delivery system includes a first capsule including a first capsule body that includes a first interior, and a first tablet and a second tablet within the first interior. The first tablet includes a first drug, and the second tablet includes at least a second drug different from the first drug. The first tablet and the second tablet are configured for simultaneous release upon dissolution of the first capsule body within a patient. The system also includes a second capsule including a second capsule body that includes a second interior, and a third tablet within the second interior. The third tablet includes the first drug.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.